Pro Share Advisors LLC Mustang Bio, Inc. Transaction History

Pro Share Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$0.58 - $1.13 $13,652 - $26,599	-23,539 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$0.73 - $1.81 $3,918 - $9,716	-5,368 Reduced 18.57%	23,539 $23,000
Q4 2021 Feb 08, 2022	BUY	$1.66 - $2.64 $47,985 - $76,314	28,907 New	28,907 $48,000
Q3 2021 Nov 12, 2021	SELL	$2.58 - $3.36 $46,581 - $60,664	-18,055 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$2.7 - $3.81 $12,420 - $17,526	4,600 Added 34.19%	18,055 $60,000

Q1 2021 May 14, 2021	BUY	$3.02 - $5.16 $6,961 - $11,893	2,305 Added 20.67%	13,455 $45,000
Q4 2020 Feb 09, 2021	BUY	$2.66 - $4.18 $29,659 - $46,607	11,150 New	11,150 $42,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $46.3M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.